角膜炎

The College of Optometrists. Clinical management guidelines: keratitis, contact lens-associated infiltrative; herpes simplex keratitis; keratitis (marginal); microbial keratitis (Acanthamoeba sp.); microbial keratitis (bacterial, fungal); photokeratitis [internet publication].全文

American Academy of Ophthalmology. Herpes simplex virus keratitis: a treatment guideline. Jun 2014 [internet publication].全文

American Academy of Ophthalmology. Bacterial keratitis​ preferred practice patterns. Nov 2018 [internet publication].全文

Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014 Oct 16;(10):CD005430.全文  摘要

Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015 Jan 9;(1):CD002898.全文  摘要

1. Rhee DJ, Pyfer MF. The Wills eye manual. Baltimore: Lippincott, Williams & Wilkins, 1999.

2. Sharma S. Keratitis. Biosci Rep. 2001 Aug;21(4):419-44. 摘要

3. Ting DSJ, Ho CS, Deshmukh R, et al. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye (Lond). 2021 Apr;35(4):1084-101.全文  摘要

4. The College of Optometrists. Clinical management guidelines: keratitis, contact lens-associated infiltrative; herpes simplex keratitis; keratitis (marginal); microbial keratitis (Acanthamoeba sp.); microbial keratitis (bacterial, fungal); photokeratitis [internet publication].全文

5. American Academy of Ophthalmology. Herpes simplex virus keratitis: a treatment guideline. Jun 2014 [internet publication].全文

6. Kinota S, Wong KW, Biswas J, et al. Changing patterns of infectious keratitis: overview of clinical and histopathologic features of keratitis due to Acanthamoeba or atypical Mycobacteria, and of infectious crystalline keratopathy. Indian J Ophthalmol. 1993 Apr;41(1):3-14. 摘要

7. Toshida H, Kogure N, Inoue N, et al. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007 Mar;33(2):70-3. 摘要

8. Brown L, Leck AK, Gichangi M, et al. The global incidence and diagnosis of fungal keratitis. Lancet Infect Dis. 2021 Mar;21(3):e49-57. 摘要

9. Gomes BF, Santhiago MR. Biology of peripheral ulcerative keratitis. Exp Eye Res. 2021 Mar;204:108458. 摘要

10. Kaiser PK, Friedman NJ. The Massachusetts eye and ear infirmary illustrated manual of ophthalmology. New York: Elsevier Science, 2004.

11. American Academy of Ophthalmology. Fungal keratitis - Asia Pacific. Oct 2016 [internet publication].全文

12. Cabrera-Aguas M, Khoo P, Watson SL. Infectious keratitis: a review. Clin Exp Ophthalmol. 2022 Jul;50(5):543-62.全文  摘要

13. Agrawal V, Biswas J, Madhavan HN, et al. Current perspectives in infectious keratitis. Indian J Ophthalmol. 1994 Dec;42(4):171-92.全文  摘要

14. Hassanpour K, H ElSheikh R, Arabi A, et al. Peripheral ulcerative keratitis: a review. J Ophthalmic Vis Res. 2022 Apr-Jun;17(2):252-75.全文  摘要

15. American Academy of Ophthalmology. Bacterial keratitis​ preferred practice patterns. Nov 2018 [internet publication].全文

16. Shahid SM, Ahmed SN, Khan Y. Eye problems in contact lens wearers. BMJ. 2019 Nov 27;367:l6337. 摘要

17. Zhang Y, Xu X, Wei Z, et al. The global epidemiology and clinical diagnosis of Acanthamoeba keratitis. J Infect Public Health. 2023 Jun;16(6):841-52.全文  摘要

18. Manikandan P, Abdel-Hadi A, Randhir Babu Singh Y, et al. Fungal keratitis: epidemiology, rapid detection, and antifungal susceptibilities of fusarium and aspergillus isolates from corneal scrapings. Biomed Res Int. 2019;2019:6395840.全文  摘要

19. American Academy of Ophthalmology. Cornea/external disease summary benchmarks - 2022. Dec 2022 [internet publication].全文

20. Tauber J, Sainz de la Maza M, Hoang-Xuan T, et al. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990 Jan;9(1):66-73. 摘要

21. Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017 Nov;124(11):1678-89.全文  摘要

22. Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014 Oct 16;(10):CD005430.全文  摘要

23. Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012 Feb;130(2):143-50.全文  摘要

24. Lalitha P, Srinivasan M, Rajaraman R, et al. Nocardia keratitis: clinical course and effect of corticosteroids. Am J Ophthalmol. 2012 Dec;154(6):934-9. 摘要

25. Garg P, Vazirani J. Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea? Expert Rev Ophthalmol. 2013;8:41-4.

26. The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. Ophthalmology. 1997 Nov;104(11):1902-9. 摘要

27. Panda A, Ahuja R, Sastry SS. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Eye (Lond). 1999 Dec;13 ( Pt 6):744-7.全文  摘要

28. Hanet MS, Jamart J, Chaves AP. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Can J Ophthalmol. 2012 Dec;47(6):493-9. 摘要

29. Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021: gonococcal infections among adolescents and adults. 2021 [internet publication].全文

30. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015 Jan 9;(1):CD002898.全文  摘要

31. Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res. 2012 Jul;37(7):654-60. 摘要

32. Guess S, Stone DU, Chodosh J, et al. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. 2007 Jul;5(3):240-50. 摘要

33. FlorCruz NV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database Syst Rev. 2015 Apr 9;(4):CD004241.全文  摘要

34. Raj N, Vanathi M, Ahmed NH, et al. Recent Perspectives in the Management of Fungal Keratitis. J Fungi (Basel). 2021 Oct 26;7(11):907.全文  摘要

35. Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008 Jul;92(7):871-8.全文  摘要

36. Alkharashi M, Lindsley K, Law HA, et al. Medical interventions for acanthamoeba keratitis. Cochrane Database Syst Rev. 2015 Feb 24;(2):CD010792.全文  摘要

37. Tu EY, Joslin CE, Shoff ME. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy. Cornea. 2010 Sep;29(9):1066-8.全文  摘要

38. Cardine S, Bourcier T, Chaumeil C, et al. [Clinical management and prognosis in Acanthamoeba keratitis: a retrospective study of 25 cases]. [in fre]. J Fr Ophtalmol. 2002 Dec;25(10):1007-13. 摘要

39. Bang S, Edell E, Eghrari AO, et al. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. Am J Ophthalmol. 2010 Jan;149(1):66-9. 摘要

40. Dana R, Farid M, Gupta PK, et al. Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy. BMC Ophthalmol. 2021 Sep 8;21(1):327.全文  摘要

41. Papaioannou L, Miligkos M, Papathanassiou M. Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis. Cornea. 2016 Jan;35(1):62-71. 摘要

42. Davis SA, Bovelle R, Han G, et al. Corneal collagen cross-linking for bacterial infectious keratitis. Cochrane Database Syst Rev. 2020 Jun 17;6(6):CD013001.全文  摘要

43. Avdagic E, Chew HF, Veldman P, et al. Resolution of Acanthamoeba keratitis with adjunctive use of oral miltefosine. Ocul Immunol Inflamm. 2021 Feb 17;29(2):278-81. 摘要

44. Thulasi P, Saeed HN, Rapuano CJ, et al. Oral miltefosine as salvage therapy for refractory Acanthamoeba keratitis. Am J Ophthalmol. 2021 Mar;223:75-82. 摘要

45. Naranjo A, Martinez JD, Miller D, et al. Systemic miltefosine as an adjunct treatment of progressive Acanthamoeba keratitis. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1576-84. 摘要

46. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006 Jan;113(1):109-16. 摘要

47. Ti SE, Scott JA, Janardhanan P, et al. Therapeutic keratoplasty for advanced suppurative keratitis. Am J Ophthalmol. 2007 May;143(5):755-62. 摘要

48. Iyer SA, Tuli SS, Wagoner RC. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens. 2006 Dec;32(6):267-71. 摘要

49. Labetoulle M, Auquier P, Conrad H, et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology. 2005 May;112(5):888-95. 摘要

50. Branco BC, Gaudio PA, Margolis TP. Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty. Br J Ophthalmol. 2004 Oct;88(10):1285-8. 摘要

51. Thebpatiphat N, Hammersmith KM, Rocha FN, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea. 2007 Jul;26(6):701-6. 摘要

52. Bhatt UK, Abdul Karim MN, Prydal JI, et al. Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts. Cochrane Database Syst Rev. 2016 Nov 30;11:CD007824.全文  摘要